Michael O’Roy

@MozoTrucho @ripster47 Me too mate me too

@ripster47 Thanks again for your apretiations! I hope $BCTX reversal soon 👍💪

$BCTX #Update Consolidation under 7 into AACR next month

@ripster47 I like $BCTX

⚡️ High Relative Volume Big Mover Scans $KRYS $SDGR $BHVN $IMVT $TERN $NNOX $AI $CLB $CSIQ $VYGR Biotech Again leading the big Volume movers continuation scan

BriaCell is a clinical stage #immunotherapy company developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors. Learn more: bit.ly/3cNVi8a $BCTX $BCTXW

Awarded Fast Track status by the U.S. Food and Drug Administration (FDA), BriaCell’s lead candidate, Bria-IMT™, is being evaluated in a Phase II clinical trial in advanced #breastcancer. Learn about Bria-IMT™: bit.ly/3q4udjN $BCTX $BCTXW

@LangmanVince Joe Biden and stimulus checks

3 years ago today gas was $2 a gallon Eggs were $1 a dozen Mortgage rates were 3% Inflation was less than 1% We had full employment, economic growth, and World Peace What happened?

2) Successful completion of the pivotal study could be followed by a Biologics License Application submission & commercialization; 3) Pivotal study's primary endpoint to be linked to survival improvement. Read the letter to shareholders here: bit.ly/401VUL9 $BCTX $BCTXW

Highlights from the letter include: 1) Positive FDA feedback on our pivotal study for lead clinical candidate Bria-IMT™ in combination with a checkpoint inhibitor could greatly accelerate the path to commercialization. bit.ly/401VUL9 $BCTX $BCTXW

BriaCell today issues a letter to shareholders from Dr. William V. Williams, BriaCell's President and CEO. Read more: bit.ly/401VUL9 $BCTX $BCTXW

@BriaCell @vanjohn10 Something’s coming soon!!! ⬆️

BriaCell recently announced positive clinical and quality of life data in advanced metastatic #breastcancer at the 2022 @SABCSSanAntonio. Find the details here: bit.ly/3BllPme $BCTX $BCTXW #SABCS22

@elonmusk NO!

Should I step down as head of Twitter? I will abide by the results of this poll.

You can Ligma Johnson

Positive efficacy data from BriaCell's Phase I/IIa clinical study of Bria-IMT™ in combination with Incyte’s retifanlimab for the treatment of advanced #breastcancer was summarized in our poster session at the @sitcancer 37th Annual Meeting. bit.ly/3ToXkKY $BCTX $BCTXW

BriaCell is pleased to announce positive initial efficacy data in its 2021-2022 cohort of 12 advanced #breastcancer patients. For details: bit.ly/3tp55G5 $BCTX $BCTXW

Disease control, tumor shrinkage, and potential survival benefit were observed amongst 12 patients in the Phase I/IIa clinical study of Bria-IMT™ in combination with Incyte’s retifanlimab. bit.ly/3tp55G5 $BCTX $BCTXW

@yatesinvesting That’s a toad. Congrats!

We are looking forward to our poster presentation, "An off-the-shelf personalized cellular approach to #immunothrapy for the treatment of advanced solid tumors" at the 2022 Society for Immunotherapy of Cancer Annual Meeting on November 10th. bit.ly/3cNMdw9 $BCTX $BCTXW

Learn how Bria-IMT™ and Bria-OTS™ destroy cancer cells: bit.ly/3fxareK $BCTX $BCTXW

@Pharmdca Getting dumped :(

$BCTX 200 SMA around $7. Over this pivot point, we could see a move towards 7.5-8 range. We have 1 conference in Nov followed by one in December.

@ripster47 when $15? #BCTX 😁😁